Advertisement
Screener

Prime Medicine, Inc. (PRME) ROA

Prime Medicine, Inc. (PRME) ROA

  • 2026-06-30: ROA -75.45%.
  • 2026-03-31: ROA -67.31%.
  • 2025-12-31: ROA -58.69%.
  • 2025-09-30: ROA -51.26%.

Complete source-backed roa history.

Available history
2021-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-75.45%
2026-03-31-67.31%
2025-12-31-58.69%
2025-09-30-51.26%
2025-06-30-71.42%
2025-03-31-61.56%
2024-12-31-65.84%
2024-09-30-65.88%
2024-06-30-83.73%
2024-03-31-65.67%
2023-12-31-102.21%
2023-09-30-71.83%
2023-06-30-53.55%
2023-03-31-43.34%
2022-12-31-33.81%
2022-09-30-67.57%
2021-12-31-54.78%

Annual ROA

DateROA
2025-12-31-58.69%
2024-12-31-65.84%
2023-12-31-102.21%
2022-12-31-33.81%
2021-12-31-54.78%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Allogene Therapeutics, Inc. (ALLO)United States$0.574B-4.33
Autolus Therapeutics plc (AUTL)$0.506B-1.52
Entera Bio Ltd. (ENTX)$0.485B
REGENXBIO Inc. (RGNX)United States$0.477B-3.30
Aura Biosciences, Inc. (AURA)United States$0.639B-5.61
Tectonic Therapeutic, Inc. (TECX)United States$0.469B-7.68
Eikon Therapeutics, Inc. (EIKN)United States$0.446B
Kyverna Therapeutics, Inc. (KYTX)United States$0.434B-3.60
Editas Medicine, Inc. (EDIT)United States$0.424B-4.29
Scribe Therapeutics, Inc. (SCTX)United States$0.410B